CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer’s disease

被引:0
|
作者
Alan J. Lerner
Steven E. Arnold
Erin Maxfield
Aaron Koenig
Maria E. Toth
Brooke Fortin
Natalia Mast
Bianca A. Trombetta
John Denker
Andrew A. Pieper
Curtis Tatsuoka
Sangeetha Raghupathy
Irina A. Pikuleva
机构
[1] Brain Health and Memory Center,Department of Neurology
[2] Neurological Institute,Alzheimer’s Clinical and Translational Research Unit
[3] University Hospitals Cleveland Medical Center,Department of Ophthalmology and Visual Sciences
[4] Case Western Reserve University,Harrington Discovery Institute
[5] Massachusetts General Hospital,Department of Psychiatry
[6] Case Western Reserve University,Institute for Transformative Molecular Medicine, School of Medicine
[7] University Hospitals Cleveland Medical Center,Department of Population and Quantitative Health Sciences
[8] Case Western Reserve University,undefined
[9] Geriatric Psychiatry,undefined
[10] GRECC,undefined
[11] Louis Stokes Cleveland VA Medical Center,undefined
[12] Case Western Reserve University,undefined
[13] Case Western Reserve University,undefined
关键词
CYP46A1; Efavirenz; Alzheimer’s disease; 24-Hydroxycholesterol; Stable isotope labeling kinetics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [32] The association between CYP46A1 rs4900442 polymorphism and the risk of Alzheimer's disease: A meta-analysis
    Jia, Fengjv
    Liu, Zhiguo
    Song, Ning
    Du, Xixun
    Xie, Junxia
    Jiang, Hong
    NEUROSCIENCE LETTERS, 2016, 620 : 83 - 87
  • [33] CYP46A1 Functional Promoter Haplotypes Decipher Genetic Susceptibility to Alzheimer's Disease (vol 21, pg 1311, 2010)
    Lia, Yan
    Chu, Leung-Wing
    Wang, Binbin
    Yik, Ping-Yiu
    Huriletemuer
    Jin, Dong-Yan
    Ma, Xu
    Song, You-Qiang
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 27 (02) : 463 - 463
  • [34] Variants of CYP46A1 interact with age and APOE to influence csf Aβ42 and phospho-tau levels in Alzheimer's disease
    Johansson, AM
    Katzov, H
    Lenhard, B
    Zetterberg, H
    Feuk, L
    Johansson, B
    Bogdanovic, N
    Andreasen, N
    Brookes, AJ
    Pederson, NL
    Blennow, K
    Prince, JA
    NEUROBIOLOGY OF AGING, 2004, 25 : S505 - S505
  • [35] Low-Dose Anti-HIV Drug Efavirenz Mitigates Retinal Vascular Lesions in a Mouse Model of Alzheimer's Disease
    El-Darzi, Nicole
    Mast, Natalia
    Buchner, David A.
    Saadane, Aicha
    Dailey, Brian
    Trichonas, Georgios
    Pikuleva, Irina A.
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [36] On the turnover of brain cholesterol in patients with Alzheimer's disease.: Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells
    Bogdanovica, N
    Bretillon, L
    Lund, EG
    Diczfalusy, U
    Lannfelt, L
    Winblad, B
    Russell, DW
    Björkhem, I
    NEUROSCIENCE LETTERS, 2001, 314 (1-2) : 45 - 48
  • [37] Microglia activation and brain glucose metabolism in early onset Alzheimer's disease: a PET study
    Iaccarino, L.
    Tondo, G.
    Presotto, L.
    Panzacchi, A.
    Coliva, A.
    Santangelo, R.
    Iannaccone, S.
    Magnani, G.
    Perani, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 199 - 199
  • [38] NPC1 enables cholesterol mobilization during long-term potentiation that can be restored in Niemann-Pick disease type C by CYP46A1 activation
    Mitroi, Daniel N.
    Pereyra-Gomez, Guadalupe
    Soto-Huelin, Beatriz
    Senovilla, Fernando
    Kobayashi, Toshihide
    Esteban, Jose A.
    Dolores Ledesma, Maria
    EMBO REPORTS, 2019, 20 (11)
  • [39] Alterations in Brain Cholesterol Metabolism in the APPSLxPS1mut mouse, a Model for Alzheimer's Disease
    Vanmierlo, Tim
    Bloks, Vincent W.
    van Vark-van der Zee, Leonie C.
    Rutten, Kris
    Kerksiek, Anja
    Friedrichs, Silvia
    Sijbrands, Eric
    Steinbusch, Harry W.
    Kuipers, Folkert
    Luetjohann, Dieter
    Mulder, Monique
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 19 (01) : 117 - 127
  • [40] Low-Dose Whole Brain Radiation Therapy For Early Alzheimer's Dementia: Early Results From A Phase IIa Trial
    Rogers, C. L.
    Lageman, S.
    Harris, T. J.
    Thomas, T.
    Boling, P.
    Karis, J.
    Shi, J.
    Fontanesi, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E747 - E747